US Stocks

PATH Stock Gains 2.7% on May 7, 2026 as UiPath Inc. Expands AI

Key Points

UiPath (PATH) stock rises 2.7% to $10.99 on May 7, 2026.

Meyka AI rates PATH with B+ grade, suggesting Buy recommendation.

Company expands agentic AI capabilities for government and regulated sectors.

Analyst consensus targets $14.07, implying 28% upside potential.

Be the first to rate this article

UiPath Inc. (NYSE: PATH) stock climbed 2.7% to $10.99 in intraday trading on May 7, 2026, as the robotic process automation leader continues positioning itself as a hidden AI play. The New York-based automation platform provider serves banking, healthcare, and government sectors with its low-code development environment. With a market cap of $5.64 billion USD, PATH stock has faced headwinds this year, down 36% year-to-date. However, recent product announcements and strong analyst sentiment suggest renewed momentum. Meyka AI rates PATH stock with a grade of B+, reflecting solid fundamentals despite near-term volatility. Earnings are scheduled for May 28, 2026.

PATH Stock Performance and Technical Setup

UiPath Inc. stock opened at $10.79 and reached a day high of $11.09, showing modest intraday strength. The 2.7% gain reflects renewed buying interest after months of pressure. PATH stock trades well below its 52-week high of $19.84, creating a potential recovery opportunity for value investors.

Technically, PATH stock sits near its 50-day moving average of $10.94, suggesting consolidation. Volume remains below average at 12.86 million shares versus the 30-day average of 31.53 million, indicating cautious positioning. The RSI at 50.34 shows neutral momentum, neither overbought nor oversold. Bollinger Bands suggest limited volatility, with the stock trading between $9.70 and $11.10.

Why PATH Stock Matters for AI Investors

UiPath positions itself as a critical infrastructure play in enterprise AI automation. The company’s platform combines artificial intelligence with robotic process automation (RPA), enabling organizations to automate complex workflows without coding expertise. Recent coverage highlights how UiPath operates as a hidden AI play within the broader automation market.

The company recently introduced on-premises agentic AI capabilities for government and regulated industries, expanding its addressable market. This move signals UiPath’s commitment to serving sectors requiring data sovereignty and compliance. With 3,868 full-time employees and operations across the US, Romania, and Japan, PATH stock benefits from diversified revenue streams and global reach.

Financial Metrics and Valuation for PATH Stock

PATH stock trades at a P/E ratio of 20.16, reasonable for a software infrastructure company with growth potential. The company generated $0.52 earnings per share trailing twelve months, with net income growing 18% year-over-year. Revenue expanded 9.3%, demonstrating steady business momentum despite market headwinds.

Key financial strengths include a current ratio of 2.48, indicating strong liquidity, and minimal debt with a debt-to-equity ratio of 0.034. Free cash flow per share reached $0.66, supporting the company’s ability to invest in R&D and product development. Track PATH on Meyka for real-time updates on these metrics and analyst coverage changes.

Market Sentiment and Analyst Consensus on PATH Stock

Analyst consensus on PATH stock remains cautiously optimistic with 12 Hold ratings, 2 Buy ratings, and 1 Sell rating. The average price target sits at $14.07, implying 28% upside from current levels. Meyka AI rates PATH with a grade of A based on fundamental analysis, factoring in S&P 500 benchmark comparison, sector performance, financial growth, and key metrics. This grade reflects strong underlying business quality despite recent stock weakness.

Institutional activity shows mixed signals. Danske Bank reduced its stake by 83.5% in Q4 2025, selling 881,301 shares, though this may reflect portfolio rebalancing rather than fundamental concerns. The company’s earnings announcement on May 28 could serve as a catalyst for PATH stock, potentially clarifying growth trajectory and AI monetization progress.

Final Thoughts

UiPath (PATH) offers a compelling opportunity for growth investors seeking enterprise AI automation exposure. With a B+ grade, solid fundamentals, and 28% upside potential from analysts, the stock shows promise despite being down 36% year-to-date. The May 28 earnings report will be crucial for confirming management’s AI strategy and revenue growth. PATH’s strong balance sheet and expanding AI capabilities position it for recovery. Investors should carefully review earnings results before deciding.

FAQs

What is the current PATH stock price and today’s movement?

PATH trades at $10.99 on May 7, 2026, up 2.7% ($0.29) from $10.70. Intraday range: $10.79–$11.09. Volume: 12.86M shares versus 30-day average of 31.53M.

Why is UiPath considered an AI stock?

UiPath combines AI with robotic process automation to automate complex workflows. It recently introduced on-premises agentic AI for regulated industries, positioning itself as enterprise AI infrastructure.

What is Meyka AI’s rating for PATH stock?

Meyka AI rates PATH as B+, reflecting strong fundamentals versus S&P 500 and sector peers. This suggests a Buy recommendation, though past performance doesn’t guarantee future results.

When is UiPath’s next earnings announcement?

UiPath reports earnings May 28, 2026, after market close. This could catalyze PATH stock by clarifying AI monetization progress and revenue acceleration trends.

What is the analyst consensus for PATH stock?

Consensus: 12 Hold, 2 Buy, 1 Sell rating. Average price target: $14.07, implying 28% upside from current $10.99 levels.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)